These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 35655531)

  • 1. Outcomes of cardiac surgery with left atrial appendage occlusion versus no Occlusion, direct oral Anticoagulants, and vitamin K Antagonists: A systematic review with Meta-analysis.
    Nso N; Nassar M; Zirkiyeva M; Lakhdar S; Shaukat T; Guzman L; Alshamam M; Foster A; Bhangal R; Badejoko S; Lyonga Ngonge A; Tabot-Tabot M; Mbome Y; Rizzo V; Munira MS; Thambidorai S
    Int J Cardiol Heart Vasc; 2022 Jun; 40():100998. PubMed ID: 35655531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive left atrial appendage occlusion plus reduced dose direct oral anticoagulant to prevent stroke in patients with atrial fibrillation-the LAAO-PlusRE.
    Besola L; Gregori D; Fiocco A; Colli A
    Ann Cardiothorac Surg; 2024 Mar; 13(2):146-154. PubMed ID: 38590988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study.
    Waranugraha Y; Lin LY; Tsai CT
    Trends Cardiovasc Med; 2024 May; 34(4):225-233. PubMed ID: 36775218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation.
    Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP
    JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies.
    Li X; Wen SN; Li SN; Bai R; Liu N; Feng L; Ruan YF; Du X; Dong JZ; Ma CS
    Heart Rhythm; 2016 Jun; 13(6):1203-14. PubMed ID: 26724488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding.
    Cimmino G; Loffredo FS; Gallinoro E; Prozzo D; Fabiani D; Cante L; Salerno G; Cappelli Bigazzi M; Golino P
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34063719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update.
    Chen S; Chun KRJ; Ling Z; Liu S; Zhu L; Wang J; Schratter A; Acou WJ; Kiuchi MG; Yin Y; Schmidt B
    J Cardiovasc Dev Dis; 2021 Jun; 8(6):. PubMed ID: 34208117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
    Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
    Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
    Oliva A; Ioppolo AM; Chiarito M; Cremonesi A; Azzano A; Miccichè E; Mangiameli A; Ariano F; Ferrante G; Reimers B; Garot P; Amabile N; Mehran R; Condorelli G; Stefanini G; Cao D
    J Am Heart Assoc; 2024 Aug; 13(16):e034815. PubMed ID: 39119987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
    Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
    Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 34187638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Efficacy and Safety of Left Atrial Appendage Occlusion (LAAO) vs Direct Oral Anticoagulation (DOAC) in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Razzack AA; Lak HM; Erasani G; Rahman S; Hussain N; Ali BF; Eapi S; Yasmin F; Najeeb H; Mustafa A; Chawla S; Munir MB; Barakat AF; Saliba W; Wazni O; Hussein AA
    Rev Cardiovasc Med; 2023 Feb; 24(2):44. PubMed ID: 39077410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical left atrial appendage occlusion during cardiac surgery: A systematic review and meta-analysis.
    Atti V; Anantha-Narayanan M; Turagam MK; Koerber S; Rao S; Viles-Gonzalez JF; Suri RM; Velagapudi P; Lakkireddy D; Benditt DG
    World J Cardiol; 2018 Nov; 10(11):242-249. PubMed ID: 30510641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis.
    Tsai YC; Phan K; Munkholm-Larsen S; Tian DH; La Meir M; Yan TD
    Eur J Cardiothorac Surg; 2015 May; 47(5):847-54. PubMed ID: 25064051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation.
    Noseworthy PA; Van Houten HK; Krumholz HM; Kent DM; Abraham NS; Graff-Radford J; Alkhouli M; Henk HJ; Shah ND; Gersh BJ; Friedman PA; Holmes DR; Yao X
    J Am Heart Assoc; 2022 Oct; 11(19):e027001. PubMed ID: 36172961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
    Carvalho PEP; Gewehr DM; Miyawaki IA; Nogueira A; Felix N; Garot P; Darmon A; Mazzone P; Preda A; Nascimento BR; Kubrusly LF; Cardoso R
    J Am Coll Cardiol; 2023 Oct; 82(18):1765-1773. PubMed ID: 37611779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage occlusion devices vs direct oral anticoagulants for atrial fibrillation: An updated systematic review and meta-analysis.
    Fernandes JM; Pinheiro RPS; Serpa F; de Andrade NM; Pereira V; Sbardelotto ÂEE; Gomes WF
    Curr Probl Cardiol; 2025 Jan; 50(1):102880. PubMed ID: 39395644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
    Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
    J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk.
    Godino C; Melillo F; Bellini B; Mazzucca M; Pivato CA; Rubino F; Figini F; Mazzone P; Della Bella P; Margonato A; Colombo A; Montorfano M
    EuroIntervention; 2020 Apr; 15(17):1548-1554. PubMed ID: 31845892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
    Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
    Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.